chr12-66211452-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_007199.3(IRAK3):c.443T>A(p.Leu148Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000277 in 1,443,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007199.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IRAK3 | NM_007199.3 | c.443T>A | p.Leu148Gln | missense_variant | 5/12 | ENST00000261233.9 | |
IRAK3 | NM_001142523.2 | c.260T>A | p.Leu87Gln | missense_variant | 4/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IRAK3 | ENST00000261233.9 | c.443T>A | p.Leu148Gln | missense_variant | 5/12 | 1 | NM_007199.3 | P1 | |
IRAK3 | ENST00000457197.2 | c.260T>A | p.Leu87Gln | missense_variant | 4/11 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250754Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135630
GnomAD4 exome AF: 0.00000277 AC: 4AN: 1443684Hom.: 0 Cov.: 30 AF XY: 0.00000556 AC XY: 4AN XY: 719604
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.443T>A (p.L148Q) alteration is located in exon 5 (coding exon 5) of the IRAK3 gene. This alteration results from a T to A substitution at nucleotide position 443, causing the leucine (L) at amino acid position 148 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at